✦ LIBER ✦

A randomized, placebo-controlled, dose-ranging study of single-dose omalizumab in patients with H1-antihistamine–refractory chronic idiopathic urticaria

✍ Scribed by Saini, Sarbjit; Rosen, Karin E.; Hsieh, Hsin-Ju; Wong, Dennis A.; Conner, Edward; Kaplan, Allen; Spector, Sheldon; Maurer, Marcus

Book ID: 119285388
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 598 KB
Volume: 128
Category: Article
ISSN: 1097-6825
DOI: 10.1016/j.jaci.2011.06.010

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase II, randomized, double-blind, pl

A phase II, randomized, double-blind, placebo-controlled, dose-ranging study of belimumab in patients with active systemic lupus erythematosus

✍ Wallace, Daniel J. ;Stohl, William ;Furie, Richard A. ;Lisse, Jeffrey R. ;McKay, 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 372 KB 👁 2 views

## Abstract ## Objective To assess the safety, tolerability, biologic activity, and efficacy of belimumab in combination with standard of care therapy (SOC) in patients with active systemic lupus erythematosus (SLE). ## Methods Patients with a Safety of Estrogens in Lupus Erythematosus: National

A Multicenter, Randomized, Double-Blind,

A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of AST-120 (Kremezin) in Patients With Moderate to Severe CKD

✍ Gerald Schulman; Rajiv Agarwal; Muralidhar Acharya; Tomas Berl; Samuel Blumentha 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 220 KB

Efficacy and Safety of Darusentan in Pat

Efficacy and Safety of Darusentan in Patients With Resistant Hypertension: Results From a Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study

✍ Henry R. Black; George L. Bakris; Michael A. Weber; Robert Weiss; Mahfouz El Sha 📂 Article 📅 2007 🏛 Le Jacq Communications, Inc. 🌐 English ⚖ 246 KB

Dose-dependent Safety and Efficacy of Zo

Dose-dependent Safety and Efficacy of Zonisamide: A Randomized, Double-blind, Placebo-controlled Study in Patients with Refractory Partial Seizures

✍ Martin J. Brodie; Roderick Duncan; Herve Vespignani; Andras Solyom; Valeriy Bite 📂 Article 📅 2005 🏛 Wiley (Blackwell Publishing) 🌐 English ⚖ 170 KB

Subcutaneous apomorphine in patients wit

Subcutaneous apomorphine in patients with advanced Parkinson's disease: A dose-escalation study with randomized, double-blind, placebo-controlled crossover evaluation of a single dose

✍ Rajesh Pahwa; William C. Koller; Richard M. Trosch; James H. Sherry 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 471 KB

A phase 1, randomized, placebo-controlle

A phase 1, randomized, placebo-controlled, 3-day, dose-ranging study of GS-5885, an NS5A inhibitor, in patients with genotype 1 hepatitis C

✍ Eric J. Lawitz; Daniel Gruener; John M. Hill; Thomas Marbury; Lisa Moorehead; An 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 830 KB